Hurdles and delays in access to anti-cancer drugs in Europe

Demographic changes in the world population will cause a significant increase in the number of new cases of cancer. To handle this challenge, societies will need to adapt how they approach cancer prevention and treatment, with changes to the development and uptake of innovative anticancer drugs play...

Descripción completa

Detalles Bibliográficos
Autores principales: Ades, F, Zardavas, D, Senterre, C, de Azambuja, E, Eniu, A, Popescu, R, Piccart, M, Parent, F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cancer Intelligence 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4263523/
https://www.ncbi.nlm.nih.gov/pubmed/25525460
http://dx.doi.org/10.3332/ecancer.2014.482

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4263523/
https://www.ncbi.nlm.nih.gov/pubmed/25525460
http://dx.doi.org/10.3332/ecancer.2014.482

Ejemplares similares